1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. California >
  6. Metabolon Acquires Lipomics Technologies

M&A Deal Summary

Metabolon Acquires Lipomics Technologies

On August 1, 2012, Metabolon acquired life science company Lipomics Technologies from Tethys Bioscience

Acquisition Highlights
  • This is Metabolon’s 1st transaction in the Life Science sector.
  • This is Metabolon’s 1st transaction in the United States.
  • This is Metabolon’s 1st transaction in California.

M&A Deal Summary
Date 2012-08-01
Target Lipomics Technologies
Sector Life Science
Buyer(s) Metabolon
Sellers(s) Tethys Bioscience
Deal Type Divestiture

Target

Lipomics Technologies

West Sacramento, California, United States
Lipomics provides metabolite profiling, biomarker discovery and metabolism consultation services to industry and academia. Its quantitative profiling assays are used to develop an understanding of metabolism in disease, the effects of drugs or foods on metabolism and for identifying biomarkers for use in clinical trials and as commercial products. Lipomics’ expertise in lipid and intermediary metabolism drives its development of research and clinical assays. Its TrueMass® Profiling is a suite of analytical panels that provide comprehensive and quantitative coverage of key pathways involved in metabolic, cardiovascular and inflammatory conditions.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Metabolon

Morrisville, North Carolina, United States
Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Metabolon is a health technology company focused on the use of metabolomics in precision medicine. Metabolon’s expertise is also accelerating research and product development across the pharmaceutical, biotechnology, consumer products, agriculture and nutrition industries, as well as academic and government organizations. Metabolon was founded in 2000 and is based in Morrisville, North Carolina.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2012 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-05 Metabolomic Discoveries

Potsdam, Germany

Metabolomic Discoveries GmbH is a research and analytics company offering concepts and solutions for complex biological questions. Metabolomic Discoveries was founded in 2009 and is based in Postdam, Germany.

Buy -

Seller(S) 1

SELLER

Tethys Bioscience

Emeryville, California, United States
Category Company
Founded 2005
Sector Healthcare Services
DESCRIPTION

Tethys Bioscience, Inc. is a predictive personalized medicine company developing novel tests whichaddress the growing global healthcare challenge of chronic diseases such as diabetes.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2012 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-09-17 Lipomics Technologies

West Sacramento, California, United States

Lipomics provides metabolite profiling, biomarker discovery and metabolism consultation services to industry and academia. Its quantitative profiling assays are used to develop an understanding of metabolism in disease, the effects of drugs or foods on metabolism and for identifying biomarkers for use in clinical trials and as commercial products. Lipomics’ expertise in lipid and intermediary metabolism drives its development of research and clinical assays. Its TrueMass® Profiling is a suite of analytical panels that provide comprehensive and quantitative coverage of key pathways involved in metabolic, cardiovascular and inflammatory conditions.

Buy -
Mergr

Solution for

Product

Company

Legal